KRAS mutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: Implication for combinatorial approach
Year: 2010
Type: article
Source: Molecular Carcinogenesis
DOI: 10.1002/mc.20607
Institution: Seoul National University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2120434825
